Paradoxical SERCA2a Dysregulation Contributes to Atrial Fibrillation in a Model of Diet-Induced Obesity
- PMID: 40565066
- PMCID: PMC12192961
- DOI: 10.3390/ijms26125603
Paradoxical SERCA2a Dysregulation Contributes to Atrial Fibrillation in a Model of Diet-Induced Obesity
Abstract
Obesity is a major risk factor for atrial fibrillation (AF), the most common serious cardiac arrhythmia, but the molecular mechanisms underlying obesity-induced AF remain unclear. In this study, we subjected mice to a chronic high-fat diet and acute sympathetic activation to investigate how obesity promotes AF. Surface electrocardiography revealed that obesity and sympathetic activation synergize during intracardiac tachypacing to induce AF. At the cellular level, this combination facilitated delayed afterdepolarizations in atrial myocytes, implicating altered Ca2+ dynamics. Interestingly, obesity did not affect the expression of key atrial Ca2+-handling proteins, including the cardiac sarcoplasmic reticulum Ca2+-ATPase (SERCA2a). However, obesity increases the proportion of inhibitory phospholamban (PLN) monomers and decreases PLN phosphorylation, suggesting reduced SERCA2a activity. Paradoxically, Ca2+ reuptake in atrial myocytes from obese mice was similar to that achieved by potent small-molecule SERCA2a activators. We found that adrenergic stimulation increased Ca2+ transient amplitude without altering Ca2+ reuptake in myocytes from obese mice. Transcriptomic analysis revealed that a high-fat diet upregulated neuronatin, a protein involved in obesity that enhances SERCA2-mediated Ca2+ reuptake in neurons. We propose that obesity enables SERCA2a activation independently of PLN regulation, while adrenergic stimulation triggers arrhythmogenic Ca2+-induced Ca2+ release, promoting AF. In conclusion, this study demonstrates that obesity causes a paradoxical dysregulation of SERCA2a in atrial myocytes, with increased activity despite higher levels of inhibitory PLN monomers and reduced PLN phosphorylation. These findings offer new insights into the cellular mechanisms of obesity-induced AF and suggest potential therapeutic targets.
Keywords: atrial fibrillation; calcium dynamics; cardiac sarcoplasmic reticulum Ca2+-ATPase SERCA; neuronatin; obesity.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures











Update of
-
Paradoxical SERCA dysregulation contributes to atrial fibrillation in a model of diet-induced obesity.bioRxiv [Preprint]. 2024 Aug 6:2024.08.02.606385. doi: 10.1101/2024.08.02.606385. bioRxiv. 2024. Update in: Int J Mol Sci. 2025 Jun 11;26(12):5603. doi: 10.3390/ijms26125603. PMID: 39149279 Free PMC article. Updated. Preprint.
References
-
- World Health Organization Obesity and Overweight. [(accessed on 15 April 2025)]. Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
-
- Powell-Wiley T.M., Poirier P., Burke L.E., Despres J.P., Gordon-Larsen P., Lavie C.J., Lear S.A., Ndumele C.E., Neeland I.J., Sanders P., et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143:e984–e1010. doi: 10.1161/CIR.0000000000000973. - DOI - PMC - PubMed
-
- Tsang T.S.M., Barnes M.E., Miyasaka Y., Cha S.S., Bailey K.R., Verzosa G.C., Seward J.B., Gersh B.J. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: A longitudinal cohort study of 21 years. Eur. Heart J. 2008;29:2227–2233. doi: 10.1093/eurheartj/ehn324. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
- R01 AI138347/AI/NIAID NIH HHS/United States
- K99 AG068309/AG/NIA NIH HHS/United States
- R01 HL176212/HL/NHLBI NIH HHS/United States
- R00AG068309/AG/NIA NIH HHS/United States
- R01 GM120142/GM/NIGMS NIH HHS/United States
- R01GM120142/GM/NIGMS NIH HHS/United States
- R01HL148068/National Heart Lung and Blood Institute
- R01AI138347/National Institute of Allergy and Infectious Diseases
- K07 AG050096/AG/NIA NIH HHS/United States
- R01 HL148068/HL/NHLBI NIH HHS/United States
- R00 AG068309/AG/NIA NIH HHS/United States
- R01 AG028082/AG/NIA NIH HHS/United States
- 20CDA35320040/American Heart Association
- R01HL176212/National Heart Lung and Blood Institute
- R35 HL155169/HL/NHLBI NIH HHS/United States
- F32 HL140728/HL/NHLBI NIH HHS/United States
- R01AG028082/AG/NIA NIH HHS/United States
- R35HL155169/National Heart Lung and Blood Institute
LinkOut - more resources
Full Text Sources